Senate Seeks Probe of FDA Policy on Advisors
Senators asked Congress’ investigative arm to look into the Food and Drug Administration’s practice of letting scientists serve on its advisory panels even if they have conflicts of interest.
“We are concerned about the process that supports FDA’s decisions to waive conflicts-of-interest rules for scientists with financial ties to the manufacturers of the products under consideration, or their competitors,” senators said in a letter to the Government Accountability Office.
It was signed by Sens. Michael B. Enzi (R-Wyo.), Edward M. Kennedy (D-Mass.) and Richard J. Durbin (D-Ill.).
Get the L.A. Times Politics newsletter
Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond. In your inbox three times per week.
You may occasionally receive promotional content from the Los Angeles Times.
